<https://rdf.molmedb.upol.cz/reference/ref1150> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM16952>;
	<http://purl.org/ontology/bibo/pmid> "19932960"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target78>,
		<https://identifiers.org/molmedb/MM00503>,
		<https://identifiers.org/molmedb/MM17000>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2009.11.004"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Pick A, Müller H, Wiese M.: Novel lead for potent inhibitors of breast cancer resistance protein (BCRP). Bioorg Med Chem Lett, Volume 20 (1), 2010"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17005>,
		<https://identifiers.org/molmedb/MM17001> .
<https://rdf.molmedb.upol.cz/transporter/tra57769> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1150> .
<https://rdf.molmedb.upol.cz/transporter/tra57801> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1150> .
<https://rdf.molmedb.upol.cz/transporter/tra57588> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1150> .
<https://rdf.molmedb.upol.cz/transporter/tra57774> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1150> .
<https://rdf.molmedb.upol.cz/transporter/tra58094> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1150> .